Down 76% This Year, Is This Growth Stock Now a Screaming Buy?
When shares of innovative growth stocks like Ginkgo Bioworks (DNA -0.28%) plummet, cunning investors know that there could be opportunity in the air. So even if a company like Ginkgo is down by more than 76% in 2022, it's a good time to take a closer look. In fact, there are a few reasons to…#ginkgobioworks #cronos #cronosgroup #ginkgo (Source: Reuters: Health)
Source: Reuters: Health - December 6, 2022 Category: Consumer Health News Source Type: news

Ginkgo Bioworks offers former West Sac Bayer employees stock options
(Source: Reuters: Health)
Source: Reuters: Health - December 4, 2022 Category: Consumer Health News Source Type: news

Ginkgo Bioworks raising $100 million, partly to pay for acquisition of Bayer's Sacramento facilities
Boston-based Ginkgo Bioworks Holdings Inc. said it plans to sell $100 million of its stock in a public offering in order to pay for its acquisition of Bayer assets in California. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 16, 2022 Category: American Health Authors: Mark Anderson Source Type: news

Health Officials Are Now Tracking COVID-19 Variants at Airports
Travelers are both the conduit and the canary in the coal mine for new COVID-19 variants, and U.S. health officials are trying to use those realities to keep ahead of variants coming into the country. At four U.S. airports—John F. Kennedy in New York, Newark in New Jersey, San Francisco International, and Atlanta Hartsfield—the Centers for Disease Control and Prevention (CDC) is partnering with private companies XpressCheck and Concentric by Ginkgo to test incoming passengers for COVID-19. (Washington Dulles is expected to join the program in November.) The testing gives the CDC a heads up on which variants are...
Source: TIME: Health - November 3, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Exclusive: Ginkgo CEO — Emeryville site could be synthetic biology incubator
Zymergen signed a 12-year lease for the biotech landmark site — once the headquarters of Chiron Corp. — and mostly completed renovations but never moved in before completing the company's sale this month to Ginkgo. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 28, 2022 Category: American Health Authors: Ron Leuty Source Type: news

The Petri Dish: Biogen SVP makes leap to Nimbus, Ginkgo partners with Saudi government
Ginkgo Bioworks is bringing its public health business to Saudi Arabia, where it will work with the Sauti government's investment arm to "add another node to a global network of pathogen monitoring infrastructure." (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 27, 2022 Category: Biotechnology Authors: Rowan Walrath Source Type: news

After Ginkgo merger wraps up, 110 job cuts planned at synthetic biology company Zymergen
The merger was completed last week, but the job cuts will start in December. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 26, 2022 Category: American Health Authors: Ron Leuty Source Type: news

Merck hires local synbio player for cell manufacturing
Merck& Company Inc. is hiring synthetic biology firm Ginkgo Bioworks Holdings Inc. to engineer a crucial component of some of its medicines. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 11, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Genes for seeds arose early in plant evolution, ferns reveal
The emergence of seed-producing plants more than 300 million years ago was an evolutionary watershed, opening new environments to plants and ultimately leading to the flowering plants that brighten our world and supply much of our food. But it was less of a leap than it seems, newly published DNA sequences suggest. The genomes, from three fern species and a cycad, one of the oldest kinds of seed-bearing plants, show genes key to making seeds are the same as those in the spore-producing machinery of ferns, which emerged tens of millions of years earlier. They evidently existed in a common ancestor but were recruited i...
Source: ScienceNOW - September 22, 2022 Category: Science Source Type: news

President Biden wants to build a 'bioeconomy.' Here's what that means for Boston.
"My view is that out-there stuff is Boston's strength," said Ginkgo Bioworks' Jason Kelly, who attended the White House's bioeconomy summit last week. "I think we should drive a truck through this. I think this is going to be a great opportunity for Boston." (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 20, 2022 Category: American Health Authors: Rowan Walrath Source Type: news

White House taps biotech executive to lead new federal biomedical agency
The Biden White House has selected an executive from Boston-based Ginkgo Bioworks as the first director of the Advanced Research Projects Agency for Health (ARPA-H) in what could be an encouraging sign for the industry leaders, advocates and politicians who have sought to establish the headquarters of the new federal biomedical agency in Boston. Renee Wegrzyn, the vice president of business development at synthetic biology firm Ginkgo Bioworks Holdings Inc. (NYSE: DNA), is set to lead ARPA-H, the … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2022 Category: Biotechnology Authors: Rowan Walrath Source Type: news

ChromaDex founder takes helm at Ginkgo Bioworks spinout
Just under a year after launching, a 'nutraceuticals' startup spun out of Ginkgo Bioworks Holdings Inc. has its first CEO. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 24, 2022 Category: American Health Authors: Rowan Walrath Source Type: news

What's behind those $381M executive paydays at Ginkgo Bioworks?
The company ’s top two executives also happen to be founders, leading to massive compensation packages for both last year. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 29, 2022 Category: Health Management Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks acquires competitor for $300M
The synthetic biology firm Ginkgo Bioworks Holdings Inc. will acquire a California company in an all-stock transaction valued at $300 million. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 25, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Developer helps bring ‘BioBus’ to Boston with Ginkgo HQ project
Some real estate firms have proposed creating job-training spaces in the life sciences projects they're building. Marcus Partners wants to take that sort of training on the road. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2022 Category: Pharmaceuticals Authors: Greg Ryan Source Type: news